Improving Risk Stratification of Emergency Department Patients With Acute Heart Failure
Part of paid clinical trials in Antioch, California.
- Sponsor
- Kaiser Permanente
- Study ID
- NCT06065761
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Comprehensive ED heart failure management tool — OTHERThe investigators plan a regional implementation of an electronic health record-based heart failure decision support tool across 21 EDs of Kaiser Permanente Northern California (KPNC).
Study Details
The primary goal is to build and test a previously developed and validated risk model and clinical decision support tool embedded within the electronic health record to improve risk stratification of emergency department (ED) patients with acute heart failure (AHF).
Key Dates
- Start date
- Jan 16, 2025
- Status verified
- May 2026
- Primary completion
- Aug 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 17,459 participants (estimated)
Primary Outcome Measure
Number of patients with risk-stratified appropriate disposition [ Time Frame: 24 hours ]
Locations (21)
Find similar trials in Antioch, CA
By condition
By specialty
By research site
Kaiser Permanente Antioch Emergency Department· Antioch, CAKaiser Permanente Fremont Emergency Department· Fremont, CAKaiser Permanente Fresno Medical Center· Fresno, CAKaiser Permanente Manteca Medical Center· Manteca, CAKaiser Permanente Modesto Medical Center· Modesto, CAKaiser Permanente Oakland Emergency Department· Oakland, CA
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart RecipientsPHASE2 · Recruiting · Baylor Research Institute · Los Angeles, California
- Metformin for Pulmonary Hypertension HFpEFPHASE2 · Recruiting · University of California, San Francisco · San Francisco, California